Co-authored by Jaume Capdevila, Medical Oncologist at the Vall d’Hebron University Hospital (HUVH) and Senior Investigator of the Vall d’Hebron…
The Lancet
Results of the study FRESCO-2 show a statistically and clinically meaningful benefit with a favorable safety profile in patients with…
Led by Toni K. Choueiri at the Dana Farber Cancer Institute, Harvard Medical School in Boston (USA), the CONTACT-03 study…
